0.28% 0.169

Amphastar Pharmaceuticals Inc (AMPH)

Finanzdaten der Amphastar Pharmaceuticals Inc-Aktie (AMPH)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	3.52% 171.84	178.10	180.56	145.71	140.02
Cost Of Revenue	0.28% 81.74	81.97	72.15	72.97	66.18
Gross Profit	6.28% 90.10	96.14	108.40	72.74	73.84
Operating Expenses	0.17% 42.09	42.16	35.73	35.84	40.41
Interest Income/Expense	8.94% 8.611	9.456	13.70	3.602	0.398
Benefits Costs and Expenses	9.36% 123.96	136.76	116.92	112.90	106.45
Costs And Expenses	9.36% 123.96	136.76	116.92	112.90	106.45
Operating Income/Loss	11.06% 48.01	53.98	72.68	36.90	33.43
Nonoperating Income/Loss	98.94% -0.134	-12.63	-9.041	-4.088	0.136
Income/Loss Before Equity Method Investments	15.77% 48.45	41.85	64.03	33.11	34.35
Income/Loss From Equity Method Investments	13.47% -0.573	-0.505	-0.39	-0.301	-0.785
Income/Loss From Continuing Operations Before Tax	15.80% 47.88	41.34	63.64	32.81	33.57
Income Tax Expense/Benefit	11.71% 4.126	4.673	14.03	6.383	6.752
Income/Loss From Continuing Operations After Tax	19.30% 43.75	36.67	49.61	26.12	26.03
Net Income/Loss	19.38% 43.18	36.17	49.22	26.12	26.03
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	46,908% 48.21	-0.103	48.70	48.40	48.00
Diluted Average Shares	1.33M% 53.01	0.004	53.92	53.10	51.97
Basic Earnings Per Share	20.00% 0.90	0.75	1.01	0.54	0.54
Diluted Earnings Per Share	17.39% 0.81	0.69	0.91	0.49	0.50
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-